How REZDIFFRA Is Reshaping the Future of NASH Treatment

أضاف وظيفة جديدة Health

2026-09-04 10:55:13 -

For decades, people living with nonalcoholic steatohepatitis had no approved pharmacological option — only lifestyle changes and watchful waiting while their liver disease quietly progressed. That changed when the FDA granted accelerated approval to resmetirom, marketed as Rezdiffra, for adults with noncirrhotic NASH and moderate-to-advanced fibrosis. It marked a genuine turning point:...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة